TETANUS
                          Prepared by:
                          SAgun PAudel
                          Health Assistant
    Student of BPH @ LA GRANDEE International college, Simalchour
                          Pokhara, Nepal
                         Presented with:
                           Rajeev Nepal




5/11/2012              Disease Presentation- TETANUS                1
Definition:
Tetanus is a acute bacterial disease caused by the
     neurotoxin tetanospasmin elaborated by
     Clostridium tetani. and characterized by a
  prolonged contraction of skeletal muscle fibers.

               It is also called lockjaw.




   5/11/2012        Disease Presentation- TETANUS   2
Causative organism:


    Clostridium tetani is a Gram-positive, obligate
    anaerobic, spore bearing and flagellate organism.
   produce a potent exotoxin called tetanospasmin.
    spores are resistant to heat and most antiseptics.




    5/11/2012      Disease Presentation- TETANUS   3
epidemiology:
   Tetanus is an international health problem, as spores
    are ubiquitous. The disease occurs almost exclusively
    in persons who are unvaccinated or inadequately
    immunized.
   Tetanus occurs worldwide but is more common in hot,
    damp climates with soil rich in organic matter.
   More common in developing and under developing
    countries.
   More prevalent in industrial establishment, where
    agricultures workers are employed.
   Tetanus neonatorum is common due to lack of MCH
    care.
     5/11/2012      Disease Presentation- TETANUS   4
Global burden:
   Tetanus, particularly the neonatal form a significant
    public health problem in non-industrialized countries.

   The World Health Organization estimates that
    59,000 newborns worldwide died in 2008 as a result
    of neonatal tetanus.




     5/11/2012       Disease Presentation- TETANUS   5
In Nepal :
 In late 2005,Nepal demonstrated through surveys that it
  had reached the WHO criterion for having eliminated
  neonatal tetanus, i.e. NT cases occurred at a rate of less
  than 1 per 1000 live births in every district.
Strategies:
 clean delivery

 routine immunization

 supplemental immunization campaigns

 surveillance




      5/11/2012       Disease Presentation- TETANUS   6
Some facts;


   Initiation of EPI in 1979 [3 districts]
   1989 in 75 districts
   DPT and TT vaccines from 1981.
years                     TT+2 COVERAGE
1993–1995                 33%

1996–2000                 45%
1999                      65%




        5/11/2012       Disease Presentation- TETANUS   7
INCUBATION PERIOD:

   Usually incubation period ranges from 3-21 days but
    can range from the day of injury to several months.

   Average incubation period is 10 days.

   Depends on character, location, and extent of
    wound.




     5/11/2012      Disease Presentation- TETANUS   8
Mode of transmission:
   Infection is acquired by contamination of wounds with
    Clostridium tetani spores. a tiny breach in skin or mucosa
    (e.g.. Skin abrasion, punctured wounds, burns, animal
    bites, unsterile surgery, aseptic abortion, unsterile
    instruments to cut umbilical cord etc.) leads to introduce
    of spores.
   the spores are widely distributed in the intestines and
    faeces of many non-human animals such as horses,
    sheep, cattle, dogs, cats, rats, guinea pigs, and chickens.
   Tetanus is not spread from person to person.


     5/11/2012       Disease Presentation- TETANUS   9
Pathogenesis:

   Tetanus begins when spores of Clostridium tetani enter
    damaged tissue.

The spores transform into rod-shaped bacteria and produce
 the neurotoxin tetanospasmin (also known as tetanus
 toxin).

This toxin is inactive inside the bacteria, but when the
  bacteria die, toxin is released and activated by proteases.

Finally it interferes with neurotransmission at spinal synapses
   of inhibitory neurons.
This results to uncontrolled spasms and reflexes.
         5/11/2012      Disease Presentation- TETANUS   10
Clinical features:
   Pain and tingling at the site of wound.
   Pain in neck, back and abdomen.
   Opisthotonos position.
   Risus sardonicus (Mouth kept slightly
    open)
   Spasm of pharyngeal muscles.
   Lock jaw (reflex trismus).
   Dysphasia.
   Acute asphyxia.
   Refusal of feeding and excessive
    crying.
   Other symptoms like fever, headache,
    etc
     5/11/2012        Disease Presentation- TETANUS   11
Diagnosis:


   There are currently no blood tests that can be
    used to diagnose tetanus.

   clinical presentation of patient associated with
    tetanus are the essential factors of diagnosis.

   history of injury and possible contamination.


    5/11/2012      Disease Presentation- TETANUS   12
Treatment:
   Injection tetanus toxoid 0.5ml intramuscularly.

   Passive immunization with human anti - tetanospasmin
    immunoglobulin.

   Local wound care:
o   Incision & drainage of pus.
o   Debridement (Removal of necrotic tissues & foreign
    bodies)
o   Wound should be open.




     5/11/2012        Disease Presentation- TETANUS   13
Treatment:
   Control of spasm:
o   Injection diazepam 0.1-0.2mg/ kg.
o   Paralyze & ventilate.

   Antibiotics:
o   Broad spectrum antibiotics to treat or prevent
    infection.

   Supportive care:
o   Isolation in a quit dark room.
o   Maintain fluid, nutrition, and electrolytes.
o   Oxygen inhalation if required.


     5/11/2012            Disease Presentation- TETANUS   14
Complications:

   Acute asphyxia
   Aspiration pneumonia
   Respiratory arrest
   Vertebral fracture
   Laceration of tongue, lips, buccal cavity.




     5/11/2012     Disease Presentation- TETANUS   15
Control and Prevention:
   Tetanus is a vaccine preventable
    disease.

   Immunization of mother with 2
    doses of TT during 2nd trimester of
    pregnancy can prevent Neonatal
    tetanus.

   Infants & children should be
    immunized by primary active
    immunization with DPT at 6, 10,14
    weeks.



     5/11/2012          Disease Presentation- TETANUS   16
Control and prevention:
   immunize the vulnerable groups such as all industrial,
    agricultural workers, armed forces etc.

   Early treatment of wound/ injury and give injection tetanus
    toxoid.

   Use of early antibiotics.
   3 clean during delivery;
     Clean hand
     Clean delivery surface
     Clean cord care.
        5/11/2012        Disease Presentation- TETANUS       17
Control and prevention:
 • Give proper health education about tetanus such as
            preventive measures, effects, etc.
  •Provide awareness that it can be prevented by post-
                 exposure prophylaxis.
•Active immunization shall protect all over them for 10
years that means adults should receive a booster
                 vaccine every ten years.




     5/11/2012         Disease Presentation- TETANUS   18
PICTURES OF CHILDREN SUFFERING FROM
TETANUS:




   5/11/2012   Disease Presentation- TETANUS   19
Children and adult man;




  5/11/2012   Disease Presentation- TETANUS   20
Picture of Suffering dog;




  5/11/2012   Disease Presentation- TETANUS   21
REFERENCES :
   www.google.com
   www.wekepedia.org
   A book of preventive and social medicine by K. park
   A test book of clinical medicine for health science by
    Dr. tilak pathak.
   Oxford journal of public health vol:31




     5/11/2012       Disease Presentation- TETANUS   22
THANK YOU………


5/11/2012     Disease Presentation- TETANUS   23
Tetanus

Tetanus

  • 1.
    TETANUS Prepared by: SAgun PAudel Health Assistant Student of BPH @ LA GRANDEE International college, Simalchour Pokhara, Nepal Presented with: Rajeev Nepal 5/11/2012 Disease Presentation- TETANUS 1
  • 2.
    Definition: Tetanus is aacute bacterial disease caused by the neurotoxin tetanospasmin elaborated by Clostridium tetani. and characterized by a prolonged contraction of skeletal muscle fibers. It is also called lockjaw. 5/11/2012 Disease Presentation- TETANUS 2
  • 3.
    Causative organism:  Clostridium tetani is a Gram-positive, obligate anaerobic, spore bearing and flagellate organism.  produce a potent exotoxin called tetanospasmin. spores are resistant to heat and most antiseptics. 5/11/2012 Disease Presentation- TETANUS 3
  • 4.
    epidemiology:  Tetanus is an international health problem, as spores are ubiquitous. The disease occurs almost exclusively in persons who are unvaccinated or inadequately immunized.  Tetanus occurs worldwide but is more common in hot, damp climates with soil rich in organic matter.  More common in developing and under developing countries.  More prevalent in industrial establishment, where agricultures workers are employed.  Tetanus neonatorum is common due to lack of MCH care. 5/11/2012 Disease Presentation- TETANUS 4
  • 5.
    Global burden:  Tetanus, particularly the neonatal form a significant public health problem in non-industrialized countries.  The World Health Organization estimates that 59,000 newborns worldwide died in 2008 as a result of neonatal tetanus. 5/11/2012 Disease Presentation- TETANUS 5
  • 6.
    In Nepal : In late 2005,Nepal demonstrated through surveys that it had reached the WHO criterion for having eliminated neonatal tetanus, i.e. NT cases occurred at a rate of less than 1 per 1000 live births in every district. Strategies:  clean delivery  routine immunization  supplemental immunization campaigns  surveillance 5/11/2012 Disease Presentation- TETANUS 6
  • 7.
    Some facts;  Initiation of EPI in 1979 [3 districts]  1989 in 75 districts  DPT and TT vaccines from 1981. years TT+2 COVERAGE 1993–1995 33% 1996–2000 45% 1999 65% 5/11/2012 Disease Presentation- TETANUS 7
  • 8.
    INCUBATION PERIOD:  Usually incubation period ranges from 3-21 days but can range from the day of injury to several months.  Average incubation period is 10 days.  Depends on character, location, and extent of wound. 5/11/2012 Disease Presentation- TETANUS 8
  • 9.
    Mode of transmission:  Infection is acquired by contamination of wounds with Clostridium tetani spores. a tiny breach in skin or mucosa (e.g.. Skin abrasion, punctured wounds, burns, animal bites, unsterile surgery, aseptic abortion, unsterile instruments to cut umbilical cord etc.) leads to introduce of spores.  the spores are widely distributed in the intestines and faeces of many non-human animals such as horses, sheep, cattle, dogs, cats, rats, guinea pigs, and chickens.  Tetanus is not spread from person to person. 5/11/2012 Disease Presentation- TETANUS 9
  • 10.
    Pathogenesis:  Tetanus begins when spores of Clostridium tetani enter damaged tissue. The spores transform into rod-shaped bacteria and produce the neurotoxin tetanospasmin (also known as tetanus toxin). This toxin is inactive inside the bacteria, but when the bacteria die, toxin is released and activated by proteases. Finally it interferes with neurotransmission at spinal synapses of inhibitory neurons. This results to uncontrolled spasms and reflexes. 5/11/2012 Disease Presentation- TETANUS 10
  • 11.
    Clinical features:  Pain and tingling at the site of wound.  Pain in neck, back and abdomen.  Opisthotonos position.  Risus sardonicus (Mouth kept slightly open)  Spasm of pharyngeal muscles.  Lock jaw (reflex trismus).  Dysphasia.  Acute asphyxia.  Refusal of feeding and excessive crying.  Other symptoms like fever, headache, etc 5/11/2012 Disease Presentation- TETANUS 11
  • 12.
    Diagnosis:  There are currently no blood tests that can be used to diagnose tetanus.  clinical presentation of patient associated with tetanus are the essential factors of diagnosis.  history of injury and possible contamination. 5/11/2012 Disease Presentation- TETANUS 12
  • 13.
    Treatment:  Injection tetanus toxoid 0.5ml intramuscularly.  Passive immunization with human anti - tetanospasmin immunoglobulin.  Local wound care: o Incision & drainage of pus. o Debridement (Removal of necrotic tissues & foreign bodies) o Wound should be open. 5/11/2012 Disease Presentation- TETANUS 13
  • 14.
    Treatment:  Control of spasm: o Injection diazepam 0.1-0.2mg/ kg. o Paralyze & ventilate.  Antibiotics: o Broad spectrum antibiotics to treat or prevent infection.  Supportive care: o Isolation in a quit dark room. o Maintain fluid, nutrition, and electrolytes. o Oxygen inhalation if required. 5/11/2012 Disease Presentation- TETANUS 14
  • 15.
    Complications:  Acute asphyxia  Aspiration pneumonia  Respiratory arrest  Vertebral fracture  Laceration of tongue, lips, buccal cavity. 5/11/2012 Disease Presentation- TETANUS 15
  • 16.
    Control and Prevention:  Tetanus is a vaccine preventable disease.  Immunization of mother with 2 doses of TT during 2nd trimester of pregnancy can prevent Neonatal tetanus.  Infants & children should be immunized by primary active immunization with DPT at 6, 10,14 weeks. 5/11/2012 Disease Presentation- TETANUS 16
  • 17.
    Control and prevention:  immunize the vulnerable groups such as all industrial, agricultural workers, armed forces etc.  Early treatment of wound/ injury and give injection tetanus toxoid.  Use of early antibiotics.  3 clean during delivery; Clean hand Clean delivery surface Clean cord care. 5/11/2012 Disease Presentation- TETANUS 17
  • 18.
    Control and prevention: • Give proper health education about tetanus such as preventive measures, effects, etc. •Provide awareness that it can be prevented by post- exposure prophylaxis. •Active immunization shall protect all over them for 10 years that means adults should receive a booster vaccine every ten years. 5/11/2012 Disease Presentation- TETANUS 18
  • 19.
    PICTURES OF CHILDRENSUFFERING FROM TETANUS: 5/11/2012 Disease Presentation- TETANUS 19
  • 20.
    Children and adultman; 5/11/2012 Disease Presentation- TETANUS 20
  • 21.
    Picture of Sufferingdog; 5/11/2012 Disease Presentation- TETANUS 21
  • 22.
    REFERENCES :  www.google.com  www.wekepedia.org  A book of preventive and social medicine by K. park  A test book of clinical medicine for health science by Dr. tilak pathak.  Oxford journal of public health vol:31 5/11/2012 Disease Presentation- TETANUS 22
  • 23.
    THANK YOU……… 5/11/2012 Disease Presentation- TETANUS 23